[A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion].
We report a case of transfusion-associated graft-versus-host disease (GVHD). A 79-year-old woman with Hodgkin's disease, respiratory failure and severe anemia who had been treated with two courses of chemotherapy was transfused with red cell concentrate (MAP-CRC) and fresh frozen plasma (FFP) in the ICU. On the 7-9th days after transfusion, she developed a diffuse erythematous rash mainly on the chest, high fever, liver dysfunction and thrombocytopenia. Despite treatment with immunoglobulin products and methylprednisolone, her condition deteriorated rapidly, and she died of multiple organ failure on the 7th day after appearance of rash. Skin biopsy demonstrated typical features of acute GVHD, suggesting that MAP-CRC-associated GVHD had occurred.
Nakamoto
T
T
Department of Anesthesiology and Intensive Care Medicine, Osaka City University Medical School.
Nishi
S
S
Shindoh
M
M
Hayashi
M
M
Yukioka
H
H
Fujimori
M
M
Maekawa
N
N
D000368:Aged; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology*; D006689:Hodgkin Disease / Q000150:complications / Q000628:therapy; D006801:Humans; D010949:Plasma